Tempo Therapeutics
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- $16M
Investors
- 1
About Tempo Therapeutics
Founded in 2014 by Westbrook Weaver (CEO) and Donald Griffin (CSO), and based in California, US, Tempo Therapeutics, Inc. operates as a biotechnology research company that develops and manufactures tissue engineering solutions for regenerative medicine using its Microporous Annealed Particle technology. In March 2024, Tempo Therapeutics, Inc. The firm pioneers tissue engineering biotechnology using its proprietary MAP (Microporous Annealed Particle) material science technology. MAP enables the creation of injectable porous scaffolds for regenerative medicine, modulating patients' immune cells for regenerative responses. Their biosurgery products address soft tissue reconstructions, improving outcomes by promoting tissue strength and function. Additionally, Tempo develops novel therapies in various therapeutic areas using MAP technology.
Who invested in Tempo Therapeutics
1 investor across 1 round
See all investors in Tempo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 1, 2024
Amount
$16M
Investors
Questions about Tempo Therapeutics
Who invested in Tempo Therapeutics?
Tempo Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tempo Therapeutics raised?
Tempo Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tempo Therapeutics last raise money?
Tempo Therapeutics's most recent round on record is a Series A, in Mar 2024.
What does Tempo Therapeutics do?
Founded in 2014 by Westbrook Weaver (CEO) and Donald Griffin (CSO), and based in California, US, Tempo Therapeutics, Inc.
Where is Tempo Therapeutics headquartered?
Tempo Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Tempo Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tempo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tempo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.